Literature DB >> 7538771

Role of interferons and other cytokines in the regulation of the immune response.

F Belardelli1.   

Abstract

Cytokines represent the major factors involved in the communication between T cells, macrophages and other immune cells in the course of an immune response to antigens and infectious agents. A number of studies on mouse and human T helper (Th) clones have recently provided extensive evidence for the existence of different activities exhibited by Th cells (called Th1 and Th2), which was apparently inferred from the profile of cytokine secretion. The Th1-type immune response is generally associated with IgG2a production and the development of cellular immunity, the Th2-type response with IgE production, eosinophils and mast cell production. This review focuses on the role of different cytokines produced by macrophages (especially interferons (IFNs), TNF-alpha, IL-10 and IL-12) or T cells (IFNs, IL-2, IL-4, IL-10, IL-13 and TGF-beta) in macrophage-T cell interactions and the cytokine relevance in the differentiation of Th cells towards the Th1 or Th2 type of immune response. Th1-derived cytokines (IFN-gamma, IL-2, TNF-alpha) favor macrophage activation, whereas the Th2 cytokines (IL-4, IL-10, IL-13) exhibit suppressive activities on macrophage functions. A key role in the differentiation towards the Th1-type response is now attributed to IL-12, a recently described cytokine produced mainly by macrophages. Its production can be upregulated by IFN-gamma and is inhibited by IL-10 and IL-4. All this emphasizes the importance of macrophage-cytokine interactions in determining the type of immune response. This article also aims to review recent data concerning the roles of IFNs alpha/beta (type I) and IFN-gamma (type II) in the regulation of the immune response. While there is much information on the regulatory effects of IFN-gamma (also called "immune IFN") on the immune response, little is so far known of the role of type I IFNs. These cytokines, originally described as simple antiviral substances, are now taken to be important regulators of the immune response. Recent data indicate that these molecules (especially IFNs-alpha) specifically promote the differentiation towards the Th1-type response. The stimulatory effects of IFN-alpha on the generation of the Th1-type response may be involved in its therapeutic effects in some human diseases, including early AIDS, hypereosinophilia and certain tumors.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538771     DOI: 10.1111/j.1699-0463.1995.tb01092.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  62 in total

1.  Type I interferon gene transfer sensitizes melanoma cells to apoptosis via a target activity on mitochondrial function.

Authors:  Paola Matarrese; Luigi Di Biase; Laura Santodonato; Elisabetta Straface; Monica Mecchia; Barbara Ascione; Giorgio Parmiani; Filippo Belardelli; Maria Ferrantini; Walter Malorni
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

2.  New sandwich-type enzyme-linked immunosorbent assay for human MxA protein in a whole blood using monoclonal antibodies against GTP-binding domain for recognition of viral infection.

Authors:  Mizuho Kawamura; Akira Kusano; Akiko Furuya; Nobuo Hanai; Hideki Tanigaki; Akihito Tomita; Akira Horiguchi; Kyosuke Nagata; Toshiko Itazawa; Yuichi Adachi; Yoshie Okabe; Toshio Miyawaki; Hiroaki Kohno
Journal:  J Clin Lab Anal       Date:  2012-05       Impact factor: 2.352

Review 3.  Clinical uses of interferons.

Authors:  Robert M Friedman
Journal:  Br J Clin Pharmacol       Date:  2007-12-07       Impact factor: 4.335

4.  Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells.

Authors:  H Vallin; S Blomberg; G V Alm; B Cederblad; L Rönnblom
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

5.  S-layer protein mediates the stimulatory effect of Lactobacillus helveticus MIMLh5 on innate immunity.

Authors:  Valentina Taverniti; Milda Stuknyte; Mario Minuzzo; Stefania Arioli; Ivano De Noni; Christian Scabiosi; Zuzet Martinez Cordova; Ilkka Junttila; Sanna Hämäläinen; Hannu Turpeinen; Diego Mora; Matti Karp; Marko Pesu; Simone Guglielmetti
Journal:  Appl Environ Microbiol       Date:  2012-12-07       Impact factor: 4.792

Review 6.  The Safety of available immunotherapy for the treatment of glioblastoma.

Authors:  S Harrison Farber; Aladine A Elsamadicy; Ahmet Fatih Atik; Carter M Suryadevara; Pakawat Chongsathidkiet; Peter E Fecci; John H Sampson
Journal:  Expert Opin Drug Saf       Date:  2017-01-03       Impact factor: 4.250

7.  Gamma interferon inhibits production of Anti-OspA borreliacidal antibody in vitro.

Authors:  Erik L Munson; Brian K Du Chateau; Jani R Jensen; Steven M Callister; David J DeCoster; Ronald F Schell
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

8.  Immune response of cytotoxic T lymphocytes and possibility of vaccine development for hepatitis C virus infection.

Authors:  Kazumasa Hiroishi; Junichi Eguchi; Shigeaki Ishii; Ayako Hiraide; Masashi Sakaki; Hiroyoshi Doi; Risa Omori; Michio Imawari
Journal:  J Biomed Biotechnol       Date:  2010-05-20

9.  Polymorphisms of some cytokines and chronic hepatitis B and C virus infection.

Authors:  Qiu-Ju Gao; Dian-Wu Liu; Shi-Yong Zhang; Min Jia; Li-Min Wang; Li-Hong Wu; Shu-Yun Wang; Li-Xin Tong
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

Review 10.  Cytokines in systemic lupus erythematosus.

Authors:  Elaine V Lourenço; Antonio La Cava
Journal:  Curr Mol Med       Date:  2009-04       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.